MedPath

DIAMETIB - DIAMETIB

Conditions
Diabetic retinopathy
Registration Number
EUCTR2004-000972-15-DK
Lead Sponsor
Michael Larsen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

diabetic retinopathy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

other eye disease

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To determine effect on visual and vascular function;Secondary Objective: To determine effect on dark adaptation;Primary end point(s): visual acuity
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath